InCROM Group initially started in Japan in 1983 and was formed by the expansion of its parent company, Rabiton Institute Inc.. In 24 years, InCROM Group has achieved year on year growth. It has evolved from a domestic company that mainly supported Phase I clinical studies in Japan to a global corporation proficient in providing total support to its international affiliated network in Phase I - IV studies.